Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study by Bakken, Inger Johanne & Ghaderi, Sara
BioMed CentralBMC Infectious Diseases
ssOpen AcceResearch article
Incidence of pelvic inflammatory disease in a large cohort of women 
tested for Chlamydia trachomatis: a historical follow-up study
Inger J Bakken*1,3 and Sara Ghaderi1,2
Address: 1Department of Preventive Health Care, SINTEF Technology and Society, Trondheim, Norway, 2Department of Mathematical Sciences, 
Faculty of Information Technology, Mathematics and Electrical Engineering, Norwegian University of Science and Technology (NTNU), 
Trondheim, Norway and 3Regional Centre for Child and Adolescent Mental Health, Department of Neuroscience, Norwegian University of Science 
and Technology (NTNU), Trondheim, Norway
Email: Inger J Bakken* - inger.j.bakken@ntnu.no; Sara Ghaderi - sarag@stud.ntnu.no
* Corresponding author    
Abstract
Background: Chlamydia trachomatis is a highly prevalent sexually transmitted disease. Testing rates
among young Norwegian women are high. Young women diagnosed with C. trachomatis are often
worried about future complications.
Methods: Our cohort consisted of 24,947 women born 1970–1984 who were tested for C.
trachomatis infection during 1990–2005. We linked C. trachomatis laboratory data to data on
hospitalizations for pelvic inflammatory disease during 1990–2005. Cox regression analysis with
time-dependent covariates adjusted for age at first test was used to assess the association between
C. trachomatis history and pelvic inflammatory disease.
Results: Follow-up until the end of 2005 included 201,387 woman-years. The incidence rate of
hospitalization for pelvic inflammatory disease was higher among women with prior C. trachomatis
infection than among women with negative tests only (48 events during 32,057 person-years and
143 events during 169,192 person-years, corresponding to 0.15 and 0.08 per 100 person-years,
respectively). The corresponding hazard ratio adjusted for age at first test was 1.69 (95% CI, 1.21–
2.36).
Conclusion: Our data show a link between a diagnosis of C. trachomatis infection and subsequent
pelvic inflammatory disease. However, pelvic inflammatory disease was a rare event irrespective of
C. trachomatis status. These, together with other recent findings, can be used to reassure women
worried about their future reproductive health following a diagnosis of C. trachomatis.
Background
Chlamydia trachomatis is a highly prevalent sexually trans-
mitted disease [1-3]. Although there is no systematic
screening program in Norway, testing rates among young
women are high, as are the positivity rates [4].
By using data from a laboratory that covers all chlamydial
diagnostics in a defined geographical area (a Norwegian
county), we have previously shown that at the age of 25,
one in six women had been diagnosed with C. trachomatis
at least once [4]. Chlamydial infections have potential
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ease, tubal factor infertility, and ectopic pregnancy [5].
Women with positive test results are often anxious about
their future fertility [6,7]. A recent review has however
shown that the previously assumed high complication
rates of C. trachomatis are now being increasingly ques-
tioned [8].
We have previously used a registry-linkage approach and
applied a retrospective cohort design to investigate ectopic
pregnancy rates and birth rates by test result among
women tested for C. trachomatis in a routine clinical set-
ting [9]. In the present study we have applied a similar
design to assess the rate of pelvic inflammatory disease
following a diagnosis of C. trachomatis.
Methods
The study was carried out in Sør-Trøndelag County, cen-
tral Norway. Of the county's 270,000 inhabitants approx-
imately 150,000 are living in the major city, Trondheim.
Data Sources
In Norway, all citizens are given a unique 11-digit social
security number at birth or at immigration. In the current
study, we used two databases, both containing the per-
sonal identifier and data on residency.
In Sør-Trøndelag County, a single laboratory is responsi-
ble for all C. trachomatis diagnostics [4]. The C. trachomatis
database contains information on all tests (date, diagnos-
tic method, and test outcome) in the county from Novem-
ber 1990 to December 2005 with person as the unit of
analysis.
Information on all hospitalizations with a diagnosis of
pelvic inflammatory disease was obtained from discharge
registries 1990–2005 of the two hospitals in the county
(Orkdal Hospital and Trondheim University Hospital).
Patients with pelvic inflammatory disease were identified
through computerized hospital in- and outpatient regis-
tries by using the International Classification of Diseases
(ICD) 9th Revision code 614 during 1990–98 and the
ICD 10th Revision codes N70 over the years 1999–2005.
Laboratory Methods
Several methods were used for C. trachomatis detection
throughout the study period[4] Briefly, the IDEIA™
Chlamydia Test, Celltech Diagnostics/Novo BioLabs/
DAKO was replaced by PACE 2™, GenProbe in 1992,
whereas Amplicor from Roche Molecular Systems became
the routine detection method in 1999.
Study Population
During November 1, 1990, to December 31, 2005,
101,649 women (all ages included) were tested for C. tra-
chomatis, among whom 68,807 resided in Sør-Trøndelag
County (Figure 1). We excluded 1,706 women without a
valid personal identifier. In order to obtain a study popu-
lation with a nearly complete testing history, we limited
the population to women who were 20 years old or
younger when computerized registration of test results
started in 1990. Thus, 42,108 women born before 1970 or
after 1984 were excluded from the study population (Fig-
ure 1). We finally excluded 46 women who were regis-
tered with a hospitalization for pelvic inflammatory
disease prior to their first registered C. trachomatis test.
Thus, our study population consisted of 24,947 women
who had not experienced a hospitalization for pelvic
inflammatory disease prior to their first C. trachomatis test.
Statistical Analysis
Confidence intervals (95%) for proportions were calcu-
lated using the Wilson method [10]. All other analyses
were carried out using SPSS for Windows, version 15.0
(SPSS, Chicago, IL).
Inclusions and exclusions of women to the studyFig re 1
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disease by C. trachomatis status we used Cox regression
analysis with months from the first C. trachomatis test as
the time variable. C. trachomatis status was entered as a
time-dependent covariate. C. trachomatis status changed at
the date of a positive test. Analyses were adjusted for age
at first test. Women were followed up until the first date
of hospitalization with a diagnosis of pelvic inflammatory
disease or censored on December 31, 2005.
Ethics
The study adheres to the Helsinki Declaration and was
approved by the Regional Committee for Research Ethics,
Central Norway, and the Norwegian Data Inspectorate.
Authorization for the use of laboratory data and data
retrieved from medical records was obtained from the
Norwegian Directorate of Health and Social Affairs.
Results
The total follow-up time from time of first C. trachomatis
infection until first hospitalization with a diagnosis of pel-
vic inflammatory disease or censoring was 201,249 per-
son-years. The average duration of the follow-up period
was 8.0 person-years (SD 4.6 person-years).
Testing Pattern
A total of 93,089 tests were registered among the 24,947
women in our study cohort during the follow-up period.
The average age at first test was 21.0 years (SD 3.7). A sin-
gle test was registered for 6,717 women (27%). Four-
thousand-seven-hundred-and-fifty women (19%) were
registered with two tests, 3,500 (14%) women had three
tests, 2,559 (10%) had four tests, and 7,421 women had
five or more tests. There was a large variation in the time
intervals between tests. We calculated the time interval
between the first two tests and the second and the third
test. For 5,408 women, both the time interval between the
first two tests and the time interval between the second
and the third test were 18 months or shorter, indicating
that 22% of the total study population were screened on a
fairly regular basis.
Positive tests
Overall, the proportion of positive tests was 6.0% (5,577/
93,089). The proportion of positive tests was highest early
in the study period and the prevalence at first test was
slightly higher than the total proportion of positive tests
(Table 1).
During the observation period, 18% of the women in the
cohort were infected with C. trachomatis at least once
(4,413/24,947). A single infection was registered for
3,513 women (14%), 701 (3%) were registered with 2
infections, and 199 (1%) with 3 or more infections.
Hospitalizations for PID
At least one hospitalization for pelvic inflammatory dis-
ease was registered for 191 out of the 24,947 women in
the cohort (0.77%).
Forty-eight out of the 4,413 women with prior C. trachom-
atis infection experienced hospitalization with a diagnosis
of pelvic inflammatory disease (1.09%; 95% CI, 0.82–
1.44). The corresponding number among the 20,534
women without prior infection was 143 (0.70%; 95% CI,
0.59–0.82).
As shown in Table 2, the incidence rate of hospitalization
with a diagnosis of pelvic inflammatory disease was
higher for women with one or more prior infections com-
pared to women with negative tests only (hazard ratio,
1.69; 95% CI 1.21–2.37).
Discussion
This registry-based cohort study shows that women diag-
nosed with C. trachomatis infection had a slightly higher
risk for hospitalization with a diagnosis of pelvic inflam-
matory disease compared to women with only negative
tests.
The present study is unique in that we had access to data
on all C. trachomatis tests over a long time period (1990–
2005) within a well-defined geographic region (county)
for a young cohort with a high testing frequency [4], at
least compared to previous registry studies [11,12]. By
comparison with data from Statistics Norway, we estimate
that our population represents approximately 80% of all
women born 1970–84 in the study area (data not shown).
We identified all cases of pelvic inflammatory disease
through hospital in-and outpatient registries.
Table 1: Total number of tests, positivity rates, number of first tests, and prevalence at first test among the women in the cohort
1990–93 1994–96 1997–99 2000–03 2004–05
All tests
Total number of tests 13,134 16,741 18,991 30,020 14,203
Proportion of positive tests 7.3% 6.2% 5.0% 6.2% 5.6%
Restricted to first test for each woman
Number of first tests 6,761 4,588 4,480 6,049 3,069
Prevalence at first test 8.0% 7.6% 5.9% 8.2% 7.6%Page 3 of 5
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data from primary care. Mildly asymptomatic cases
treated outside hospital settings or asymptomatic cases are
missed. Although such cases also might have potential for
long-term adverse reproductive health effects, hospitaliza-
tions are likely to reflect the most severe cases of pelvic
inflammatory disease. Another limitation of our study is
that the study population consists of women tested for C.
trachomatis in a routine clinical setting. Because the
women were not systematically screened, the number of
tests for each woman varied, as did the interval between
tests. Furthermore, over the study period, there was a
change in test technology towards more sensitive tests.
Finally, we did not have access to other data of potential
interest, such as sexual activity and contraception use.
We found a higher incidence rate of pelvic inflammatory
disease among women diagnosed with C. trachomatis
infection than among women with negative tests only.
This result is in concordance with results from a Swedish
registry-linkage study [12]. The risk estimate was however
slightly lower in that study compared to ours, possibly
because we had access to more recent and complete data
on both C. trachomatis testing and pelvic inflammatory
disease hospitalizations (1990–2005 for both exposure
and outcome). In the Swedish study, the C. trachomatis
database covered the time period 1985–1996, while out-
comes were assessed until 1999. Missing data on testing
history and a large proportion of tests analyzed with less
sensitive technology will tend to bias the results towards
the null because of misclassification of infection status.
Although the present study showed higher incidence rates
of pelvic inflammatory disease among women with prior
positive tests than among women with negative tests only,
the rates were low in either group. It has been suggested
that the relatively low incidence of lower genital tract
complications among women diagnosed with C. trachom-
atis infection indicates that the benefits of chlamydia
screening programs might have been overestimated [12].
However, the present and previous registry studies include
women tested for C. trachomatis in routine clinical settings
[9,11-13], and it is most unlikely that a large proportion
of women with a diagnosis were left untreated. Thus, the
high prevalence rate of infection together with the low
incidence rates of complications among women with pos-
itive tests might rather indicate that screening for chlamy-
dial infection benefits female reproductive health. Such
findings do however show that women with positive test
results, often anxious about their future fertility [6,7], can
be reassured that the risk of long term reproductive health
consequences is low after a treated infection.
Conclusion
The present study shows a clear link between diagnosed C.
trachomatis infection and subsequent pelvic inflammatory
disease. However, hospitalization for pelvic inflammatory
disease was a rare event also among women with prior
infections. This, held together with previous findings of
low ectopic pregnancy rates also among women with
prior infection, might indicate that the large-scale oppor-
tunistic screening for C. trachomatis over the last decades
has enhanced the reproductive health of Norwegian
women.
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